Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Saturday, November 2, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Saturday, November 2, 2024 | Latest Paper
Subscribe Now

TRENDING:

Par Nijhawan

Federal support for host-directed therapeutics will help prepare for future health emergencies

  • With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.
Opinion | BY PAR NIJHAWAN | August 7, 2023
A pedestrian walks past a COVID-19 themed mural outside Ottawa City Hall in January 2021. A new class of host-directed therapeutics could provide protection from both anticipated and unanticipated threats to our population, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade

Federal support for host-directed therapeutics will help prepare for future health emergencies

Opinion | BY PAR NIJHAWAN | August 7, 2023
  • With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.

Federal support for host-directed therapeutics will help prepare for future health emergencies

Opinion | BY PAR NIJHAWAN | August 7, 2023
  • With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.
A pedestrian walks past a COVID-19 themed mural outside Ottawa City Hall in January 2021. A new class of host-directed therapeutics could provide protection from both anticipated and unanticipated threats to our population, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade

Federal support for host-directed therapeutics will help prepare for future health emergencies

  • With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.
Opinion | BY PAR NIJHAWAN | August 7, 2023
A pedestrian walks past a COVID-19 themed mural outside Ottawa City Hall in January 2021. A new class of host-directed therapeutics could provide protection from both anticipated and unanticipated threats to our population, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade

Federal support for host-directed therapeutics will help prepare for future health emergencies

Opinion | BY PAR NIJHAWAN | August 7, 2023
  • With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.

Federal support for host-directed therapeutics will help prepare for future health emergencies

Opinion | BY PAR NIJHAWAN | August 7, 2023
  • With continued support, HDTs have the potential to become an important tool in both pandemic preparedness and biodefence for Canada and our global partners.
A pedestrian walks past a COVID-19 themed mural outside Ottawa City Hall in January 2021. A new class of host-directed therapeutics could provide protection from both anticipated and unanticipated threats to our population, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade

Canada is up to the challenge of Omicron

  • For many, the COVID-19 pandemic brought tragedy and challenge. Yet, through all the hardships, governments and citizens bet on science to defeat COVID-19. That
Opinion | BY PAR NIJHAWAN | December 9, 2021
François-Philippe Champagne was named Canada's innovation minister in January 2021. While there is much to praise about the Canadian commitment to science and innovation, this country still faces many challenges to becoming a leader in homegrown, innovative medicine, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade

Canada is up to the challenge of Omicron

Opinion | BY PAR NIJHAWAN | December 9, 2021
  • For many, the COVID-19 pandemic brought tragedy and challenge. Yet, through all the hardships, governments and citizens bet on science to defeat COVID-19. That

Canada is up to the challenge of Omicron

Opinion | BY PAR NIJHAWAN | December 9, 2021
  • For many, the COVID-19 pandemic brought tragedy and challenge. Yet, through all the hardships, governments and citizens bet on science to defeat COVID-19. That
François-Philippe Champagne was named Canada's innovation minister in January 2021. While there is much to praise about the Canadian commitment to science and innovation, this country still faces many challenges to becoming a leader in homegrown, innovative medicine, writes Dr. Par Nijhawan. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu